S&P 500   2,995.68 (+1.00%)
DOW   27,024.80 (+0.89%)
QQQ   193.52 (+1.27%)
AAPL   235.32 (-0.23%)
FB   188.89 (+3.06%)
MSFT   141.58 (+1.45%)
AMZN   1,767.38 (+1.78%)
CGC   20.10 (+6.57%)
NVDA   196.37 (+5.28%)
TSLA   257.89 (+0.36%)
AMD   30.72 (+0.62%)
F   9.07 (+2.83%)
ACB   3.76 (+7.12%)
NFLX   284.25 (-0.45%)
BAC   29.73 (+2.02%)
GILD   65.30 (+1.22%)
S&P 500   2,995.68 (+1.00%)
DOW   27,024.80 (+0.89%)
QQQ   193.52 (+1.27%)
AAPL   235.32 (-0.23%)
FB   188.89 (+3.06%)
MSFT   141.58 (+1.45%)
AMZN   1,767.38 (+1.78%)
CGC   20.10 (+6.57%)
NVDA   196.37 (+5.28%)
TSLA   257.89 (+0.36%)
AMD   30.72 (+0.62%)
F   9.07 (+2.83%)
ACB   3.76 (+7.12%)
NFLX   284.25 (-0.45%)
BAC   29.73 (+2.02%)
GILD   65.30 (+1.22%)
Log in

Melinta Therapeutics Stock Chart (NASDAQ:MLNT)

$4.16
+0.24 (+6.12 %)
(As of 10/15/2019 04:00 PM ET)
Today's Range
$3.83
Now: $4.16
$4.20
50-Day Range
$2.21
MA: $3.08
$3.90
52-Week Range
$1.62
Now: $4.16
$20.00
Volume423,210 shs
Average Volume444,296 shs
Market Capitalization$57.20 million
P/E RatioN/A
Dividend YieldN/A
Beta4.54
This page was last updated on 10/15/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel